Page 10 - Ram Prasad Sahu/workspace/business Standard Web/video

Launch thrust to power volume engine of PV maker Maruti Suzuki India

Firing on all cylinders: New models to steer it through cost bumps, sector drag

Robust revenue growth, margin recovery ahead for Tata Consumer Products

While most brokerages have built in healthy revenue and profit delivery by the company over the next few years, the stock may not see much upside given high valuations

Havells slides 5% on cautious demand outlook; here are key Q4 takeaways

Havells' management highlighted that consumer sentiment remains subdued due to persistent inflation

Dixon hits 3-month high, stock rebounds 36% from April low; here's why

The stock was the biggest gainer in the BSE 200 index on Tuesday and ended the day with a 5.35 per cent rise

Core biz recovery, biryani bet boost Devyani International outlook

Analysts positive on planned acquisition, upgrade the stock

Hospital valuations keep steady pulse, ensuring growth never skips a beat

Administering the right dose for asset-light expansion and steady margins

Outlook for Wipro trimmed after weak guidance, muted Q4 revenue show

India's fourth largest software company continues to underperform compared to peers

Automobiles to pharma & healthcare: Earnings winter to persist in Q4FY25

Past champions such as banks, oil & gas and automotive seen as laggards

Multiple headwinds to keep tiles sector under pressure in the near term

The ultra-luxury apartments demonstrate significant demand, driven by rising disposable incomes and a preference for high-end options

Stock downfall: The side effects are real, but Sun Pharma stays on its feet

Growth hormone kicks in as India's largest pharma firm's vital signs hold amid generic strain

Near-term headwinds may keep Metropolis Healthcare under pressure

The near-term triggers for the stock are the March quarter (Q4FY25) performance and the acquisition of Dr Ahujas' Pathology and Imaging Centre (DAPIC) earlier this week

FMCG stocks gain as RBI cuts FY26 inflation est; GCPL, HUL rise up to 2%

The RBI MPC, on Wednesday, unanimously decided to cut the repo rate by 25 basis points, bringing it down to 6 per cent, from 6.25 per cent earlier.

IndiGo stock hits all-time high; surges 12% in 1-month on healthy outlook

The brokerage has been structurally positive on IndiGo driven by business moats of cost competitiveness, robust orderbook and strong balance sheet

Growth worries, competitive pressures weigh on Trent stock performance

Elara Securities expects gross margin for the March quarter to come down by 71 basis points quarter-on-quarter and 129 basis points year-on-year due to seasonality

Warning lights flash for ER&D companies as auto sector runs low on fuel

ER&D downshifts on weak Q4, gloomy 2025; more downgrades loom

Pharma companies likely to pass on costs in US as fresh levy looms

Brokerages also felt that the pharma companies will aim to pass on the tariff hike to payors

Higher tariffs may significantly dent profits of pharma companies

Companies such as Sun Pharma which have a significant specialty portfolio could be less impacted than Indian peers in the US market given lower competition in niche segments

Fizz is back in Varun Beverages stock as launches, summer boost outlook

The key concern weighing on the stock is increased competitive intensity with the relaunch of Campa Cola by Reliance Consumer Products (RCPL) in March 2023

Pharmaceutical growth cure lies in CDMOs' resilience to market ailments

They get growth Rx from outsourcing, with fewer Trump tariff side effects

Reits climb the office ladder even as valuations keep rungs in place

Realty index in the rearview as office demand pulls Reits out of a two-year slump